In converse to the finding that RUNX2 upregulates BAX expression in the SAOS-2 cell line [108], nitric oxide (NO) treatment of the MG-63 osteosarcoma cell line induces RUNX2-mediated BCL2 expression, which promotes survival of the cells during oxidative stress [111]. This evidence concerns the gene RUNX2 and osteosarcoma.